Pulsed Field Ablation | On Demand
Presented at the 29th Annual International AF Symposium February 2024
Pulsed Field Ablation - New Clinical Trial Evidence
Moderators: Meleze Hocini, MD and Gerhard Hindricks, MD
All lectures 7 minutes. Panel Discussion 25 minutes.
PULSED-AF Study
David DeLurgio, MD
INSPIRE Study
Tom De Potter, MD
ADVENT Study
Moussa Mansour, MD
MANIFEST-PF and MANIFEST-17K
Vivek Reddy, MD
Non-Pulmonary Vein Targets with Pulsed Field Ablation
Melanie Gunawardene, MD
Panel and Audience Discussion – All Faculty
Pulsed Field Ablation - Efficiency and Safety
Moderators: Devi Nair, MD and Luigi Di Biase, MD, PhD
All lectures 7 minutes. Panel Discussion 25 minutes.
Efficiency of Pulsed Field Ablation - Ease of Use and Comparison with RF Ablation
Ante Anic, MD
General Anesthesia vs Sedation & Other Workflow Considerations for Pulsed Field Ablation
Julian Chun, MD
Coronary Artery Spasm During PFA – Review of Clinical Evidence and Prevention
Edward Gerstenfeld, MD
Safety Considerations with Pulsed Field Ablation - Esophagus, Phrenic N., Cerebral Lesions, & Hemolysis
Thomas Deneke, MD
FDA Policy Update on Evaluation of New Technologies for AF Management
Aneesh Deoras, MSE, Assistant Director for Cardiac Ablation, Mapping, and Imaging Devices, Office of Cardiovascular Devices, CDRH,
US FDA
Panel and Audience Discussion – All Faculty
Pulsed Field Ablation - Optimizing Lesion Delivery and Future Directions in Technology
Moderators: David Haines, MD and Pierre Jais, MD
All lectures 7 minutes. Panel Discussion 25 minutes.
Durability of PVI with Pulsed Field Ablation - Results and Significance of Remapping Studies
Devi Nair, MD
Optimizing Pulsed Field Ablation Lesion Parameters
Jacob Koruth, MD
PFA Catheter Designs: Small Tip Focal, Large Tip Focal, and Single Shot
Pierre Jais, MD
First in Human Experience with Novel Pulsed Field Ablation Technologies
Andrea Natale, MD
Future Technologies in Pulsed Field Ablation
Vivek Reddy, MD
Panel and Audience Discussion - All Faculty & Andrew Farb, MD, Chief Medical Officer, Office of Cardiovascular Devices, CDRH, US FDA